Medicare Drug Cuts Target CVD Meds, Drive Debates
CardiacWire
AUGUST 18, 2024
If these first 10 reductions were in place in 2023, it would have cut $6B in prescription costs, which actually represents a much smaller 22% net reduction due to these drugs’ pre-existing Medicare discounts and rebates. The post Medicare Drug Cuts Target CVD Meds, Drive Debates appeared first on Cardiac Wire.
59 
Let's personalize your content